• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Thrombosis/Thrombus (4440)
Event Date 08/13/2021
Event Type  Injury  
Manufacturer Narrative
(b)(6).
 
Event Description
Clinical trial (b)(6).It was reported that in-stent thrombosis occurred.The subject was enrolled in the (b)(6) clinical study on (b)(6) 2018 and the index procedure was performed on the same day.The target lesion was 70% stenosis located in the right distal superficial femoral artery (sfa), 60 mm long with a proximal reference vessel diameter of 8 mm and distal reference vessel diameter of 6 mm and was classified as a tasc ii a lesion.The target lesion was treated with direct placement of a 6 mm x 60 mm eluvia drug-eluting vascular stent system.Following post-dilation, residual stenosis was 18%.The subject was discharged with antiplatelet therapy the next day.On (b)(6) 2021, 980 days post-index procedure, the subject presented due to recently worsening lower limb pain without trophic disorder and a complete thrombosis noted in the right sfa stent.Doppler ultrasound examination of the lower extremity arterial system revealed the stent completely thrombosed with a resumption of patency in the region of the proximal popliteal artery with subsequent demodulated and dampened flow in the three arteries of the leg, which were still perfectly patent.The common femoral artery was nicely patent, however, a large posterior calcified plaque, without anything to suggest significant stenosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12481288
MDR Text Key271690996
Report Number2134265-2021-11623
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 09/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/16/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/02/2019
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0021887981
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/25/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/06/2018
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age65 YR
-
-